Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.

“Germany’s Bayer, the drugs and pesticides maker, has inked a deal to buy a British biotech firm to boost its women’s healthcare business, with an initial $425 million payment agreed.” (Source: Guardian)

Highlights

Bayer is acquiring menopause biotech company KaNDy Therapeutics; Nurx adds $22.5M in new funding and announces plans for new migraine treatments; Stix, a startup offering D2C pregnancy & ovulation tests, raises a $1.3M seed round; Women’s health startup Kliit Health rebrands as Kiira; Equip launches a virtual eating disorder treatment program; Zomato, one of India’s biggest food delivery companies, is introducing a ‘period leave’ program, GoodRx files for IPO; ‘Disgusting’ study rating the attractiveness of women with endometriosis is finally retracted after 7 years

Spotlight

Big news from Bayer & KaNDy Therapeutics this week! So what else is happening in the biotech space when it comes to women’s health? Let’s have a look at a couple of companies!

KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on treating multiple symptoms of the menopause.

YourChoice Therapeutics is revolutionizing birth control options for women and men by developing hormone-free contraceptives and bringing them to market.

The FDA has recently approved Evofem Biosciences’ Phexxi, a non-hormonal prescription gel for the prevention of pregnancy.

Celmatix is a data-driven, research-stage precision health company leveraging insights from its proprietary multi-omic discovery platform, Reproductive Atlas, to develop transformational therapeutics in previously underserved areas of women’s health.

In the Know

We Need to Talk about Investors’ Problems with Vaginas (WIRED)

As Mindfulness App Headspace Booms, It’s Popularity Outpaces Its Scientific Evidence (STAT)

What a Doctor Learns from Watching You on Video Chat (The Atlantic)

America is Failing Black Moms During the Pandemic (Vox)

Fertility Diary: I am Stranded an Ocean Away from My Embryos (Refinery29)

Femtech Market Has Unmet Segments Despite Industry Growth, Report Says (MobiHealthNews)

During Coronavirus Lockdowns, Doctors Wondered: Where Are the Preemies? (NY Times)

Better Care is Needed for Postpartum Depression (Medium)

BBC Women’s Sport Survey: Periods, the Pill and the Effect of Female Athletes (BBC)

Who’s Hiring? 

Prelude Fertility is looking for a Medical Assistant.

Ovy is hiring a Graphic Designer.

Peanut is looking for a Community Operations Manager.

Elvie is hiring a Senior Product Manager.

Syrona is looking for an Experienced Gynecologist.

Want to see more jobs? Click HERE

Show CommentsClose Comments

Leave a comment